Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial

American Journal of Kidney Diseases · Elsevier

Аннотация

Publication date: Available online 13 November 2026 Source: American Heart Journal Author(s): Shao-Wei Lo, Darae Ko, Dae Hyun Kim, Long H. Ngo, Daniel E Singer, Sachin J Shah

Читать у издателя →

Похожие статьи